Blair & Company

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: 60 Arch Street Greenwich CT 06830 United States of America Tel: 203 661 8790 Fax: 203 661 7261 Email:

Loading...

Recent Publications by Blair & Company:
Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone. OBJECTIVE: To investigate the efficacy and tolerability of direct...	4th July, 2008	Centre hospitalier universitaire, psychiatrie B, place Henri-Dunand, 63003	Encephale. 2008 Apr;34(2):170-8. Epub 2007 Nov 1. DOI Direct Link
Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. In this study, we analysed 30 patients with B-cell chronic lymphocytic...	24th June, 2008	Laboratory of Experimental Oncology D, National Institute for Cancer	Leukemia. 2008 May;22(5):980-8. Epub 2008 Feb 21. DOI Direct Link
The inhibitory collagen receptor LAIR-1 (CD305). The immune system protects the body from invaders such as viruses and...	5th June, 2008	Department of Immunology, University Medical Center, Utrecht 3584 EA, The	J Leukoc Biol. 2008 Apr;83(4):799-803. Epub 2007 Dec 6. DOI Direct Link
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. BACKGROUND: In high grade gliomas, 1p19q codeletion and EGFR amplification...	22nd May, 2008	Unite INSERM U711, Universite Paris VI, 47-83 Boulevard de l'Hopital,	Mol Cancer. 2008 May 20;7:41. DOI Direct Link
Transfer of tolerance to heart and kidney allografts in the rat model. Long-term allograft acceptance can be induced in the rat using a variety...	2nd May, 2008	INSERM U643, Institut de transplantation et de recherche en	Transpl Int. 2008 Mar;21(3):199-206. Epub 2007 Dec 5. DOI Direct Link
→View more Blair & Company research publications.

BioNews Results for Blair & Company:
Cancer patients transferred to Saskatoon	Star Phoenix:  Jul 17 2008 2:32PM Matching: blair
Dyax enters negotiation period with Dompe for angioedema drug	Pharmaceutical Business Review:  Jul 17 2008 1:02PM Matching: blair
Dyax enters into an exclusive negotiation period with Dompe for European license to DX-88 in Angioedema indica	Checkbiotech:  Jul 16 2008 4:25PM Matching: blair
Dyax Enters into an Exclusive Negotiation Period with Dompe for European License to DX-88 in Angioedema Indica	DiGiTAL50:  Jul 16 2008 3:29PM Matching: blair
Dyax enters into an exclusive negotiation period with Dompe for european license to DX-88 in Angioedema indica	Checkbiotech:  Jul 16 2008 2:16PM Matching: blair
Promote your company here: BioNewsCast - Press Release Distribution	→View more Blair & Company news.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 53 individuals from Blair & Company using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 236 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Greenwich

Search for more companies in CT

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Blair & Company

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.